Evans DG - Search Results

1

Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Evans DG, Watson C, King A, Wallace AJ, Baser ME. Evans DG, et al. J Med Genet. 2005 Jan;42(1):45-8. doi: 10.1136/jmg.2004.023705. J Med Genet. 2005. PMID: 15635074 Free PMC article.

2

Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.

Wallace AJ, Watson CJ, Oward E, Evans DG, Elles RG. Wallace AJ, et al. Among authors: evans dg. Genet Test. 2004 Winter;8(4):368-80. doi: 10.1089/gte.2004.8.368. Genet Test. 2004. PMID: 15684865 Clinical Trial.

3

Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.

Baser ME, Mautner VF, Parry DM, Evans DG. Baser ME, et al. Among authors: evans dg. J Med Genet. 2005 Dec;42(12):903-6. doi: 10.1136/jmg.2005.031302. Epub 2005 Apr 14. J Med Genet. 2005. PMID: 15831594 Free PMC article. Review.

4

The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG. Baser ME, et al. Among authors: evans dg. J Med Genet. 2005 Jul;42(7):540-6. doi: 10.1136/jmg.2004.029504. J Med Genet. 2005. PMID: 15994874 Free PMC article. Review.

5

Evans DG, Maher ER, Baser ME. Evans DG, et al. J Med Genet. 2005 Aug;42(8):630-2. doi: 10.1136/jmg.2004.027953. J Med Genet. 2005. PMID: 16061561 Free PMC article.

6

Management of the patient and family with neurofibromatosis 2: a consensus conference statement.

Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R. Evans DG, et al. Br J Neurosurg. 2005 Feb;19(1):5-12. doi: 10.1080/02688690500081206. Br J Neurosurg. 2005. PMID: 16147576 Review.

7

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Evans DG, et al. J Med Genet. 2006 Apr;43(4):289-94. doi: 10.1136/jmg.2005.036319. Epub 2005 Sep 9. J Med Genet. 2006. PMID: 16155191 Free PMC article. Review.

8

Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?

Evans DG, Ramsden RT, Gokhale C, Bowers N, Huson SM, Wallace A. Evans DG, et al. Clin Genet. 2007 Apr;71(4):354-8. doi: 10.1111/j.1399-0004.2007.00778.x. Clin Genet. 2007. PMID: 17470137

9

Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.

Hadfield KD, Newman WG, Bowers NL, Wallace A, Bolger C, Colley A, McCann E, Trump D, Prescott T, Evans DG. Hadfield KD, et al. Among authors: evans dg. J Med Genet. 2008 Jun;45(6):332-9. doi: 10.1136/jmg.2007.056499. Epub 2008 Feb 19. J Med Genet. 2008. PMID: 18285426

10

An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).

Evans DG, Wallace A. Evans DG, et al. J Med Genet. 2009 Nov;46(11):792. doi: 10.1136/jmg.2009.070342. J Med Genet. 2009. PMID: 19880713 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,360 results

Search Page

Filters